Nothing Special   »   [go: up one dir, main page]

ES8200011A1 - Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa. - Google Patents

Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.

Info

Publication number
ES8200011A1
ES8200011A1 ES488788A ES488788A ES8200011A1 ES 8200011 A1 ES8200011 A1 ES 8200011A1 ES 488788 A ES488788 A ES 488788A ES 488788 A ES488788 A ES 488788A ES 8200011 A1 ES8200011 A1 ES 8200011A1
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
diphenylhydantoin
derivative
preparation
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488788A
Other languages
English (en)
Other versions
ES488788A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National des Radioelements IRE
Original Assignee
Institut National des Radioelements IRE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National des Radioelements IRE filed Critical Institut National des Radioelements IRE
Publication of ES488788A0 publication Critical patent/ES488788A0/es
Publication of ES8200011A1 publication Critical patent/ES8200011A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE UNA COMPOSICION FARMACEUTICA, EN PARTICULAR PSICOTROPA, QUE CONTIENE COMO SUSTANCIA ACTIVA UN DERIVADO DE FENILHIDANTOINA. SE MEZCLA UN VEHICULO Y/O UN EXCIPIENTE SOLIDO O LIQUIDO, INERTE, NO TOXICO, UTILIZADO EN FARMACIA GALENICA, CON UNA FANILHIDANTOINA DE FORMULA (I), EN DONDE LOS RADICALES R1 PUEDEN SER IGUALES O DIFERENTES Y SON UN ATOMO DE HIDROGENO O UN GRUPO METILO; R2 ES UN GRUPO ETILO O FENILO, DEUTERIZADO O NO; R3 ES UN ATOMO DE HIDROGENO O DE HALOGENO O UN RADICAL ALQUILO QUE TIENE DE 1 A 4 ATOMOS DE CARBONO, UN RADICAL ALCOXI CON IGUAL NUMERO DE ATOMOS DE CARBONO, UN RADICAL TRIFLUOROMETILO, HIDROXI, NITRO O AMINO; X ES UN AGRUPAMIENTO OXO, TIO O METILENO Y "X" ES UN NUMERO ENTERO COMPRENDIDO ENTRE 1 Y 5.
ES488788A 1979-02-20 1980-02-20 Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa. Expired ES8200011A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7904209A FR2449448B1 (fr) 1979-02-20 1979-02-20 Composition pharmaceutique comprenant un derive de phenylhydantoine, derives mis en oeuvre et leur preparation

Publications (2)

Publication Number Publication Date
ES488788A0 ES488788A0 (es) 1981-10-16
ES8200011A1 true ES8200011A1 (es) 1981-10-16

Family

ID=9222166

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488788A Expired ES8200011A1 (es) 1979-02-20 1980-02-20 Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.

Country Status (11)

Country Link
US (1) US4304782A (es)
EP (1) EP0015038B1 (es)
JP (1) JPS55133362A (es)
AT (1) ATE10804T1 (es)
CA (1) CA1139672A (es)
DE (1) DE3069813D1 (es)
DK (1) DK71780A (es)
ES (1) ES8200011A1 (es)
FI (1) FI71556C (es)
FR (1) FR2449448B1 (es)
NO (1) NO152047C (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106837B2 (ja) * 1989-01-31 1995-11-15 シャープ株式会社 シート状体の循環式供給装置
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
JPH04297461A (ja) * 1991-03-27 1992-10-21 Otsuka Pharmaceut Factory Inc ２−チオヒダントイン誘導体
US6334997B1 (en) * 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
BR9507200A (pt) * 1994-03-25 1997-09-16 Isotechnika Inc Melhora da eficácia de drogas por deuteração
AU1917899A (en) * 1998-03-20 1999-10-18 Warner-Lambert Company Crystalline sodium phenytoin monohydrate
US6054590A (en) * 1998-03-25 2000-04-25 Bristol-Myers Squibb Company Imidazolone anorectic agents: II. phenyl derivatives
DE10214228A1 (de) * 2002-03-22 2003-10-02 Bdd Group Holding Ag Zug Deuterierte substitutierte Indole sowie diese Verbindungen enthaltende Arzneimittel
WO2005060661A2 (en) * 2003-12-19 2005-07-07 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies
NZ550102A (en) * 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) * 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
SI2004181T1 (sl) 2006-03-27 2016-07-29 The Regents Of The University Of California Modulator androgenskega receptorja za zdravljenje raka na prostati in bolezni povezane z androgenskim receptorjem
KR101600230B1 (ko) 2006-03-29 2016-03-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴티오히단토인 화합물
TWI557111B (zh) 2007-10-26 2016-11-11 加州大學董事會 二芳基乙內醯脲類化合物
MX355915B (es) 2010-02-16 2018-05-04 Aragon Pharmaceuticals Inc Moduladores del receptor de androgenos y usos de los mismos.
SG10201912719TA (en) 2012-09-26 2020-02-27 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
KR20240096623A (ko) 2017-10-16 2024-06-26 아라곤 파마슈티컬스, 인코포레이티드 비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐

Also Published As

Publication number Publication date
CA1139672A (en) 1983-01-18
NO152047B (no) 1985-04-15
JPS55133362A (en) 1980-10-17
ES488788A0 (es) 1981-10-16
FI71556B (fi) 1986-10-10
FR2449448A1 (fr) 1980-09-19
EP0015038B1 (fr) 1984-12-19
FR2449448B1 (fr) 1983-05-27
NO152047C (no) 1985-07-24
NO800447L (no) 1980-08-21
ATE10804T1 (de) 1985-01-15
FI800502A (fi) 1980-08-21
DK71780A (da) 1980-08-21
EP0015038A1 (fr) 1980-09-03
DE3069813D1 (en) 1985-01-31
FI71556C (fi) 1987-01-19
US4304782A (en) 1981-12-08

Similar Documents

Publication Publication Date Title
ES8200011A1 (es) Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.
HUP9903707A2 (hu) 17Béta-karboxi-,-tio-karboxi-vagy -amido-androsztánszármazékok laktonszármazékai, előállításuk, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
IE46158L (en) Propanolamine derivatives
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
HUP9801356A2 (hu) Triciklusos (2-hidroxi-2-metil-3,3,3-trifluor-propanoil)-amino-benzoxepin-, -benzotiepin-, -benzocikloheptén-, -indén-származékok és az ezeket tartalmazó gyógyszerkészítmények
ES463411A1 (es) Procedimiento para la preparacion de nuevas fluoracil-resor-cinas sustituidas.
ES8506635A1 (es) Un procedimiento para la preparacion de derivados de acilmorfinano
ATE74352T1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
SE7501365L (es)
AU643290B2 (en) Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application
ES8203867A1 (es) Procedimiento para la obtencion de derivados de benzotiazol
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ES8105309A1 (es) Un procedimiento para la preparacion de nuevos derivados de cromano.
ES435361A1 (es) Un metodo para la preparacion de nuevos esteres alcohilicosde aminoacidos.
IL60176A0 (en) Xanthine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
ES8201539A1 (es) Procedimiento de preparacion de nuevas ortoarilideneaminofe-netilaminas y de sus sales de adicion con acidos farmacolo- gicamente compatibles
ES2027492A6 (es) Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables.
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ES2006336A6 (es) Procedimiento de preparacion de nuevas acetamidas derivadas de la 2,3-dihidro-3-fenil-2-benzofuranona.
ES8600203A1 (es) Procedimiento de preparacion de nuevos derivados aminoetoxibencilalcoholicos y de sus sales de adicion acidas y amonicas cuaternarias
GB2006196A (en) Phenylacetamides with analgesic activity
ES457996A1 (es) Un procedimiento para la preparacion de nuevos derivados de morfolina.
IE35788B1 (en) Benzodiazepines